Cleared Traditional

K864889 - OMNI-TRAK

K864889 is an FDA 510(k) clearance for OMNI-TRAK, manufactured by Invivo Research Labs, Inc.. The device is a Class 2 Cardiovascular device with product code DSB cleared through the Traditional 510(k) pathway after a 84-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1987
Decision
84d
Days
Class 2
Risk

K864889 is an FDA 510(k) clearance for the OMNI-TRAK. Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.

Submitted by Invivo Research Labs, Inc. (Tulsa, US). The FDA issued a Cleared decision on March 6, 1987 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K864889

510(k) Number K864889 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 1986
Decision Date March 06, 1987
Days to Decision 84 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 125d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DSB Device Classification - Class 2, Special Controls

Product Code DSB Plethysmograph, Impedance
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSB Plethysmograph, Impedance

All 114
Devices cleared under the same product code (DSB) and FDA review panel - the closest regulatory comparables to K864889.
BIODYNAMICS MODEL BI-300 BODY COMPOSITION ANALYZER
K874361 · Biodynamics Corp. · Mar 1988
CONSULTANT BODY COMPOSITION ANALYZER
K871040 · Body Composition Analog, Inc. · Jun 1987
BODY WATCH BODY COMPOSITION ANALYZER MODEL 2010
K863833 · Body Watch, Inc. · Mar 1987
MODIFIED MODEL BIA-103 BODY COMPOSITION ANALYZER
K862383 · Rjl Systems, Inc. · Feb 1987
1990A BIO-RESISTANCE BODY COMPOSITION ANALYZER
K861205 · Valhalla Scientific · Jan 1987
BILATERAL IMPEDANCE PLETHYSMOGRAPH, BIP(TM)
K862714 · Electro-Diagnostic Instruments · Nov 1986